Neuronetics
Open enrollment with a later-stage pipeline tilt
According to ClinicalTrials.gov-derived indexes, Neuronetics sits in the top decile of US sponsors by registered trial count (#1,226 of 15,742 sponsors by registered trial count).
Neuronetics: 11 sponsored US clinical trials, 3 recruiting.
Neuronetics sponsors 11 registered US clinical trials on ClinicalTrials.gov, 3 of them currently recruiting, and 6 completed. 1 of these trials are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Anxiety Depression, with 2 trials.
Top-decile sponsor footprint
Neuronetics ranks in the top decile of sponsors by registered trial count (#1,226 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Open and recent trials
11 total, page 1 of 1
Accelerated TMS for MDD
NCT07147218
Retrospective Analyses of the Greenbrook Database Evaluating Mental Health Treatments
NCT06997549
Retrospective Analyses of TrakStar Database
NCT06917339
Symptom Evaluation Following Repetitive Transcranial Magnetic Stimulation
NCT06429748
A Retrospective Study to Evaluate NeuroStar® Advanced Therapy in Adolescents
NCT06699940
Study to Evaluate Treatment Effects Associated With the NeuroStar SoftStart Treatment Feature
NCT05535062
Safety and Effectiveness of NeuroStar® Transcranial Magnetic Stimulation (TMS) Therapy in Depressed Adolescents
NCT02586688
Efficacy and Safety Study of NeuroStar TMS Therapy in Patients With Major Depressive Disorder With Postpartum Onset
NCT01842542
Maintenance NeuroStar Transcranial Magnetic Stimulation (TMS) in Patients With Major Depressive Disorder
NCT01415154
NeuroStar TMS Therapy System: Utilization and Outcomes
NCT01114477
Study of a Repetitive Transcranial Magnetic Stimulation (rTMS) Device for the Treatment of Major Depressive Disorder
NCT00104611
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 3 | 1 |
Therapeutic Areas
Where Neuronetics enrollment is open (later-stage tilt)
3 recruiting of 11 indexed (27% open); 6 completed (55%).
Phase mix: 1 late (III/IV) vs 0 early (I/II) (later-stage heavy).
Top condition: Anxiety Depression (2 trials), 5 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Neuronetics: open-pipeline peers nationwide
Peers matched on 11 registered trials and 27% open enrollment, not the therapeutic-area sidebar.
Neuronetics sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 11 trials (± recruiting share)
- Aderans Research Institute · 11 trials · 0% recruiting
- Aegerion Pharmaceuticals · 11 trials · 0% recruiting
- Allena Pharmaceuticals · 11 trials · 0% recruiting
- AOBiome · 11 trials · 0% recruiting
Sponsors near 27% open enrollment (± trial volume)
- Connecticut Children's Medical Center · 27% recruiting · 55 trials
- Criterium · 27% recruiting · 11 trials
- Minneapolis Heart Institute Foundation · 27% recruiting · 22 trials
- Nerviano Medical Sciences · 27% recruiting · 11 trials
Related
What to do with this Neuronetics page
11 registered trials is a research-attention snapshot, not an endorsement of Neuronetics or any single study.
- 3 of Neuronetics's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Anxiety Depression is the condition Neuronetics studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Anxiety Depression trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Neuronetics pipeline card: 11 registered trials from official public datasets.Report a data error.